Bicycle Therapeutics BCYC
NASDAQ BCYC
$4.26 +0.03 (+0.59%)
As of: Sep 4, 2026 · 3:13 PM EDT

Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026)

Bicycle Therapeutics' (BCYC) quarterly Other Non-Current Assets came in at $12.7 million in Q2 2026, down 8.26% YoY from $13.8 million in Q2 2025, and down 2.49% on a QoQ basis from $13.0 million in Q1 2026.

Analysis

Bicycle Therapeutics (BCYC) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Bicycle Therapeutics (BCYC) has 9 years of Other Non-Current Assets data on file, last reported at $12.7 million in Q2 2026.

  • Quarterly Other Non-Current Assets fell 8.26% year-over-year to $12.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.7 million (down 8.26% YoY) and the FY2025 annual result came in at $12.8 million, up 15.63% from the prior year.
  • Other Non-Current Assets slipped to $12.7 million in Q2 2026, from $13.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $13.8 million in Q2 2025 to a low of $4.2 million in Q1 2022.
  • A 5-year average of $9.5 million and a median of $10.3 million in 2023 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 151.69% — and 2024, when it sank 45.83%.
  • Tracing BCYC's Other Non-Current Assets over 5 years: stood at $8.5 million in 2022, then tumbled by 31.52% to $5.8 million in 2023, then jumped by 91.19% to $11.1 million in 2024, then increased by 15.63% to $12.8 million in 2025, then declined by 1.07% to $12.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $12.7 million (Q2 2026), $13.0 million (Q1 2026), and $12.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 124.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 42.45 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 62.96 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
10 Bicycle Therapeutics 297.72 Mn 297.72 Mn - 12.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.67 Mn
Mar 31, 2026 12.99 Mn
Dec 31, 2025 12.81 Mn
Sep 30, 2025 13.71 Mn
Jun 30, 2025 13.81 Mn
Mar 31, 2025 12.36 Mn
Dec 31, 2024 11.07 Mn
Sep 30, 2024 9.94 Mn
Jun 30, 2024 6.58 Mn
Mar 31, 2024 6.37 Mn
Dec 31, 2023 5.79 Mn
Sep 30, 2023 5.45 Mn
Jun 30, 2023 12.15 Mn
Mar 31, 2023 10.57 Mn
Dec 31, 2022 8.46 Mn
Sep 30, 2022 6.16 Mn
Jun 30, 2022 5.10 Mn
Mar 31, 2022 4.20 Mn
Dec 31, 2021 3.45 Mn
Sep 30, 2021 2.78 Mn